ArticleInternational journal of cancer2024
Obesity is associated with biliary tract cancer mortality and incidence: A pooled analysis of 21 cohort studies in the Asia Cohort Consortium.
Open access · bronzeAbstract read
In one paragraph
Article in International journal of cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 9 citations in OpenAlex.
- Global burden landscape (1990-2021) of gallbladder and biliary tract cancer attributable to high body mass index in older adults and a projection to 2050.Journal of gastrointestinal oncology · 2026Article
- Global, regional, and national burden of gallbladder and biliary tract cancer from 1990 to 2021 and projections to 2050: a systematic analysis integrating the Global Burden of Disease 2021 and Mendelian randomization.International journal of surgery (London, England) · 2026Article
- Visceral adipose tissue-to-blood pool standardized uptake ratio byInternational journal of clinical oncology · 2026Article
- Obesity and Cancer: Mechanisms, Epidemiological Evidence, and Potential Risk Reduction.Journal of obesity & metabolic syndrome · 2026Review
- Impact of high body mass index on gallbladder and biliary tract cancer burden in China: a comprehensive analysis of trends from 1990 to 2021.World journal of surgical oncology · 2024Article
- Epidemiology of biliary tract cancer in China: A narrative review.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2024Article
- Body Mass Index and Risk of Colorectal Cancer Incidence and Mortality in Asia.JAMA network open · 2024Article
- Not Only Metabolic Complications of Childhood Obesity.Nutrients · 2024Review
- An analysis of the global burden of gallbladder and biliary tract cancer attributable to high BMI in 204 countries and territories: 1990-2021.Frontiers in nutrition · 2024Article
- C-reactive Protein-to-Albumin Ratio as a Superior Inflammatory Marker in Resected Biliary Tract Cancer: Development of a Prognostic Nomogram Complementary to TNM Staging.Cancer diagnosis & prognosisArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
46 authors at 20 institutions in 9 countries.
Isao OzeDivision of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.ORCID 0000-0002-0762-1147
Hidemi ItoDivision of Cancer Information and Control, Department of Preventive Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan.ORCID 0000-0002-8023-4581
Yuriko N KoyanagiDivision of Cancer Information and Control, Department of Preventive Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan.ORCID 0000-0002-5675-3429
Sarah Krull AbeDivision of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan.ORCID 0000-0003-3991-2739
Md Shafiur RahmanDivision of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
Md Rashedul IslamDivision of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
Eiko SaitoInstitute for Global Health Policy Research, National Center for Global Health and Medicine, Tokyo, Japan.ORCID 0000-0002-4550-9631
Prakash C GuptaHealis-Sekhsaria Institute for Public Health, Navi Mumbai, India.
Norie SawadaDivision of Cohort Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan.ORCID 0000-0002-9936-1476
Akiko TamakoshiDepartment of Public Health, Hokkaido University Faculty of Medicine, Sapporo, Japan.
Xiao-Ou ShuDivision of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0002-0711-8314
Ritsu SakataRadiation Effects Research Foundation, Hiroshima, Japan.
Reza MalekzadehDigestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Ichiro TsujiTohoku University Graduate School of Medicine, Miyagi, Japan.
Jeongseon KimGraduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.ORCID 0000-0002-0889-2686
Chisato NagataDepartment of Epidemiology and Preventive Medicine, Gifu University Graduate School of Medicine, Gifu, Japan.
San-Lin YouSchool of Medicine & Big Data Research Center, Fu Jen Catholic University, Taipei, Taiwan.ORCID 0000-0002-3192-3356
Sue K ParkDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0001-5002-9707
Jian-Min YuanDivision of Cancer Control and Population Sciences, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0000-0002-4620-3108
Myung-Hee ShinDepartment of Social and Preventive Medicine, Sungkyunkwan University School of Medicine, Gyeonggi-do, Korea.
Sun-Seog KweonDepartment of Preventive Medicine, Chonnam National University Medical School, Gwangju, Korea.
Mangesh S PednekarHealis-Sekhsaria Institute for Public Health, Navi Mumbai, India.
Shoichiro TsuganeDivision of Cohort Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
Takashi KimuraDepartment of Public Health, Hokkaido University Faculty of Medicine, Sapporo, Japan.
Yu-Tang GaoDepartment of Epidemiology, Shanghai Cancer Institute, Shanghai, China.
Hui CaiDivision of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Akram PourshamsDigestive Diseases Research institute, Tehran University of Medical Science, Tehran, Iran.
Yukai LuTohoku University Graduate School of Medicine, Miyagi, Japan.
Seiki KanemuraTohoku University Graduate School of Medicine, Miyagi, Japan.
Keiko WadaDepartment of Epidemiology and Preventive Medicine, Gifu University Graduate School of Medicine, Gifu, Japan.ORCID 0000-0002-5467-8592
Yumi SugawaraTohoku University Graduate School of Medicine, Miyagi, Japan.ORCID 0000-0002-0197-6772
Chien-Jen ChenGenomics Research Center, Academia Sinica, Taipei, Taiwan.
Yu ChenDepartments of Population Health and Environmental Medicine, NYU Grossman School of Medicine, New York, New York, USA.ORCID 0000-0002-1519-4894
Aesun ShinDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0002-6426-1969
Renwei WangDivision of Cancer Control and Population Sciences, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Yoon-Ok AhnDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Min-Ho ShinDepartment of Preventive Medicine, Chonnam National University Medical School, Gwangju, Korea.
Habibul AhsanDepartment of Public Health Sciences, University of Chicago, Chicago, Illinois, USA.
Paolo BoffettaStony Brook Cancer Center, Stony Brook University, Stony Brook, New York, USA.
Kee Seng ChiaSaw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.
You-Lin QiaoSchool of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID 0000-0001-6380-0871
Nathaniel RothmanDivision of Cancer Epidemiology and Genetics, Occupational and Environmental Epidemiology Branch, National Cancer Institute, Bethesda, Maryland, USA.ORCID 0000-0002-0866-9943
Wei ZhengDivision of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0003-1226-070X
Manami InoueDivision of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan.ORCID 0000-0003-1276-2398
Daehee KangSeoul National University College of Medicine, Seoul, Korea.ORCID 0000-0003-4031-5878
Keitaro MatsuoDivision of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.ORCID 0000-0003-1761-6314
Aichi Cancer Center · JPSeoul National University · KRTohoku University · JPChonnam National University Hospital · KRVanderbilt University Medical Center · USGifu University · JPHealis Sekhsaria Institute For Public Health · INHokkaido University · JPChicago Department of Public Health · USChinese Academy of Medical Sciences & Peking Union Medical College · CNFu Jen Catholic University · TWGenomics Research Center, Academia Sinica · TWHamamatsu University School of Medicine · JPHitotsubashi University · JPNational Cancer Center · KRNational Cancer Institute · USNational Center for Global Health and Medicine · JPNational Institute of Infectious Diseases · JPNational University of Singapore · SGNew York University · US
Funding
Prospective studies of cancer etiology and prevention in Shanghai and SingaporeR01CA144034 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YUAN, JIAN-MIN · 2010 to 2014
$7.0MShanghai Womens Health StudyUM1CA182910 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ZHENG, WEI · 2014 to 2018
$5.9MDIETARY FACTORS IN THE ETIOLOGY OF CANCER IN SHANGHAIR01CA043092 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI YUAN, JIAN-MIN · 1987 to 2006
$5.8MShanghai Men's Health StudyUM1CA173640 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SHU, XIAO-OU · 2013 to 2017
$4.9MCancer Risk Reduction and Diet: A Cohort Study of WomenR37CA070867 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ZHENG, WEI · 2009 to 2013
$4.7MCancer epidemiology cohorts in Shanghai and Singapore UM1CA182876 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YUAN, JIAN-MIN · 2014 to 2018
$4.3MUpper Gastrointestinal Cancer StudiesZ01CP000185 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI DAWSEY, SANFORD M · 2005 to 2008
$1.4MIntramural NIH HHS Z01 CP000185NCI NIH HHS R01 CA043092NCI NIH HHS R01 CA144034NCI NIH HHS R37 CA070867NCI NIH HHS UM1 CA173640NCI NIH HHS UM1 CA182876NCI NIH HHS UM1 CA182910NIEHS NIH HHSNIH HHS R01CA0403092NIH HHS R01CA144034NIH HHS UM1CA182876
Abstract
Body fatness is considered a probable risk factor for biliary tract cancer (BTC), whereas cholelithiasis is an established factor. Nevertheless, although obesity is an established risk factor for cholelithiasis, previous studies of the association of body mass index (BMI) and BTC did not take the effect of cholelithiasis fully into account. To better understand the effect of BMI on BTC, we conducted a pooled analysis using population-based cohort studies in Asians. In total, 905 530 subjects from 21 cohort studies participating in the Asia Cohort Consortium were included. BMI was categorized into four groups: underweight (<18.5 kg/m
Indexed as
Biliary Tract NeoplasmsCholelithiasisAsiaBody Mass IndexCohort StudiesFemaleHumansMaleObesityOverweightRisk FactorsAsia Cohort Consortiumbiliary tract cancerbody mass indexobesitypooled analysis
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.